The PROMPPT Trial
The PROMPPT trial aims to test the effectiveness of the PROMPPT intervention (the training package, the pain review, patient facing information and documents) to reduce opioid use in patients prescribed …
Good Clinical Practice
GCP stands for good clinical practice and is an Internationally recognised standard for conducting a clinical trial. It enforces tight guidelines on ethical aspects of a clinical study High standards …
Safety Reporting
Patient safety is of paramount importance in clinical research and safety reporting is a critical part of the PROMPPT trial. The pain review is considered to be evidence-based best practice …
MOPP-2 Process Evaluation
When evaluating interventions, it is important to not only assess the effectiveness of the intervention but to also explore the reasons as to why and how it works or doesn’t …
Pain Reviews
In this section we will outline how you can go about scheduling pain reviews and give you some guidance on completing relevant study documents. It is anticipated that you will …
MOPP Questionnaire Study
The MOPP questionnaire study will ask participants from all GP practices involved in the trial to complete a baseline (with embedded consent), 3, 6 and 12 month questionnaire. The questionnaire …
Involving the whole practice
The involvement of the whole practice (including administrative and healthcare professional team members) is important to enable the delivery of the trial. All documentation for the questionnaire study (MOPP) and …
Why PROMPPT?
Watch Dr Roger Knaggs talk about the problem of long-term opioids, the current situation in primary care and why pharmacists are well placed to have conversations with patients about the …
Welcome to the PROMPPT research programme
PROMPPT is an NIHR funded research programme and stands for: Proactive clinical Review of patients taking Opioid Medicines long-term for persistent Pain led by clinical Pharmacists in primary care Teams PROMPPT is formed of three linked …
